ArisGlobal, a provider of solutions to the life sciences industry, announced the agCenter? 3.1, a clinical research investigator site portal that facilitates and streamlines the communication and collaboration between sponsors and their clinical study sites.
ArisGlobal, a provider of solutions to the life sciences industry, announced the agCenter™ 3.1, a clinical research investigator site portal that facilitates and streamlines the communication and collaboration between sponsors and their clinical study sites. agCenter addresses a key challenge that sponsors face in how to best retain and recruit investigators who often experience difficulties in meeting their study obligations. The investigator portal is the newest addition to ArisGlobal’s Total Clinical™, a comprehensive platform for clinical research that includes EDC, CTMS, ePRO, medical coding, trial disclosure, supply chain management and safety reporting -- all accessed via agWorld™, a central clinical portal.
“Finding and engaging with clinical study sites is becoming increasingly challenging labor-intensive and expensive, especially with today’s complex, global trials,” commented Simon Sparkes, senior vice president and head of the Clinical and Compliance business units at ArisGlobal. “As a result, all Sponsors are looking for ways to improve site relationships while containing costs. As EDC reaches almost full adoption, Sponsors now recognize that investigator portals represent an important step forward in improving site relationships, reducing site start-up times and also reducing the high cost of site management.”
From its intuitive dashboard, agCenter offers the full range of functionality to meet the needs of both sponsors and investigators:
agCenter 3.1 will be delivered to customers as a cloud-based solution via agOnDemand™, ArisGlobal's highly proven Software-as-a-Service (SaaS) delivery platform.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.